Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Neuland Laboratories Limited
NEULANDLAB | NSE
16,964.00
INR153.00
0.91%
NEULANDLAB | NSE
Loading StockChartView...
About Neuland Laboratories Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
08/06/2026
Close
16,964.00
Open
16,794.00
High
17,028.00
Low
16,401.00
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India Europe the United States and internationally. The company's APIs are used in various therapeutic areas including antiasthmatics cardiovasculars antifungal anticonvulsants central nervous system fluoroquinolones antipsychotic antibacterial and anti-parkinson. It also provides custom manufacturing solutions as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad India.
View LessNEULANDLAB | NSE
Risk
24.9
Sharpe
1.06
Luna's Score
58/100
Recommendation
Hold
Luna says (NEULANDLAB | NSE)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
20.5%1 month
24.9%3 months
40.8%6 months
41.3%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
53.76
Fwd. PE
18.45
Price to book
14.09
Debt to equity
0.07
Debt to assets
0.05
Ent. to EBITDA
34.57
Ent. to rev.
11.33
PEG
-
Other Fundamentals
EBITDA
4.84B
MarketCap
238.20B
MarketCap(USD)
2.49B
Div. yield
0.10
Op. margin
24.36
Erngs. growth
58.20
Rev. growth
21.10
Ret. on equity
26.36
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.28K
Range1M
2.40K
Range3M
6.80K
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.44
Price X volume
551.33M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 34.57 | 24.85 | Expensive |
| Ent. to Revenue | 11.33 | 11.40 | Par |
| PE Ratio | 53.76 | 51.36 | Par |
| Price to Book | 14.09 | 6.83 | Expensive |
| Dividend Yield | 0.10 | 0.52 | Poor |
| Std. Deviation (3M) | 40.79 | 42.17 | Par |
| Debt to Equity | 0.07 | 0.35 | Cheaper |
| Debt to Assets | 0.05 | 0.17 | Cheaper |
| Market Cap | 238.20B | 290.82B | Par |
